← brief for 2026-08-31 · Slowing decline

Ruxolitinib prevents irreversible autoimmune endocrinopathies in APECED.

Key takeaways

In two people with a rare genetic disorder that causes multiple autoimmune problems, a drug called ruxolitinib lowered inflammation and helped prevent hormone gland damage. This is not a trial — just two case reports, so it is too early to know if it helps most people.

Who did this work

Pechacek J · Webb T · Dos Santos Dias L · Wu R · Moorman H · Barber P · Rosen LB · Burbelo PD · Colton B · Guzman H · Sacta M · McCormack SE

Source

Article · PubMed, CKD progression and prevention · 2026 Aug 1
https://pubmed.ncbi.nlm.nih.gov/42669680/